Merit Financial Group’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,360
Closed -$100K 1698
2025
Q1
$100K Buy
+13,360
New +$100K ﹤0.01% 1355